source
- AIDS activists criticize Biden-Gilead R&D settlement over HIV prevention patentsA group of AIDS activists have secured an R&D agreement that sits at the core of a settlement between the U.S. government and Gilead Sciences concerning patents on HIV prevention drugs. The activi…
- Freenome's updated blood test shows stronger detection of precancerous lesions, boosting Abbott's market prospectsFreenome announced that its revised SimpleScreen CRC blood test met both primary and secondary goals in a pivotal validation study. The new data indicate better performance than the earlier version…